On November 13, 2018 the Sarcopenia Definitions and Outcomes Consortium (SDOC) held a conference in Boston, MA to share its work on developing an evidence-based consensus definition of sarcopenia. The SDOC was formed to develop and evaluate diagnostic cut-points for low muscle mass and muscle strength that predicts increased risk of mobility disability and health outcomes. This year’s meeting brought together an International Expert Panel to vote on key position statements for a consensus-based definition of the condition. This webinar is a recap of the SDOC meeting with its organizers.
Shalender Bhasin, MB, BS
Professor of Medicine, Harvard Medical School; Director, Research Program in Men’s Health: Aging and Metabolism; Director, Boston Claude D. Pepper Older Americans Independence Center; Brigham and Women’s Hospital
Peggy Cawthon, PhD, MPH
Professor of Epidemiology & Biostatistics, UCSF School of Medicine; Senior Scientist, California Pacific Medical Center Research Institute
Jack Guralnik, MD, PhD, MPH (Moderator)
Chair, Aging in Motion Science Advisory Board Chair; Professor of Epidemiology & Public Health, University of Maryland School of Medicine